天津医药 ›› 2023, Vol. 51 ›› Issue (5): 487-490.doi: 10.11958/20221258

• 实验研究 • 上一篇    下一篇

桑黄素通过抑制TXNIP/NLRP3/Caspase-1信号通路对脑缺血再灌注大鼠神经元凋亡的影响

薛丽(), 韩红, 张力   

  1. 武汉市第四医院康复医学科(邮编430000)
  • 收稿日期:2022-08-11 修回日期:2022-11-23 出版日期:2023-05-15 发布日期:2023-05-05
  • 作者简介:薛丽(1990),女,住院医师,主要从事神经康复、骨科康复方面研究。E-mail:xueli1990xl@163.com
  • 基金资助:
    武汉市卫生和计划生育委员会资助项目(WZ18Q07)

Effects of Morin on neuronal apoptosis in cerebral ischemia-reperfusion rats by inhibiting TXNIP/NLRP3/Caspase-1 signaling pathway

XUE Li(), HAN Hong, ZHANG Li   

  1. Department of Rehabilitation Medicine, Wuhan Fourth Hospital, Wuhan 430000, China
  • Received:2022-08-11 Revised:2022-11-23 Published:2023-05-15 Online:2023-05-05

摘要:

目的 探讨桑黄素(Morin)通过调控硫氧还蛋白互作蛋白(TXNIP)/核苷酸结合寡聚化结构域样受体蛋白3(NLRP3)/胱天蛋白酶1(Caspase-1)信号通路,对脑缺血再灌注大鼠神经元凋亡的影响。方法 将60只大鼠随机均分为假手术组、模型组、Morin低剂量(Morin-L,10 mg/kg)组、Morin高剂量(Morin-H,40 mg/kg)组、Morin-H+pLVX-NC组(40 mg/kg Morin+ pLVX-NC)、Morin-H+pLVX-TXNIP组(40 mg/kg Morin+pLVX-TXNIP)。采用线栓法制作大鼠大脑中动脉栓塞模型(除外假手术组),给药1 h后再灌注。再灌注72 h后,进行神经功能缺损评分;取出全脑进行脑含水量测定;苏木精-伊红(HE)染色观察脑皮质半暗带病理损伤情况;2,3,5-氯化三苯基四氮唑(TTC)检测脑组织梗死面积;酶联免疫吸附试验检测血清中白细胞介素(IL)-1β、IL-18含量;Western blot检测脑皮质中TXNIP/NLRP3/Caspase-1信号通路蛋白表达水平。结果 与假手术组比较,模型组神经功能缺损评分,IL-1β、IL-18水平,脑含水量,梗死面积,TXNIP、NLRP3、Caspase-1蛋白表达均增加(P<0.05);与模型组比较,Morin-L组、Morin-H组神经功能缺损评分,IL-1β、IL-18水平,脑含水量,梗死面积,TXNIP、NLRP3、Caspase-1蛋白表达均降低(P<0.05);与Morin-H+pLVX-NC组比较,Morin-H+pLVX-TXNIP组神经功能缺损评分,IL-1β、IL-18水平,脑含水量,梗死面积,TXNIP、NLRP3、Caspase-1蛋白表达增加(P<0.05)。结论 Morin可以减轻脑缺血再灌注大鼠脑损伤,抑制神经元凋亡,作用机制可能与抑制TXNIP/NLRP3/Caspase-1信号通路活化有关。

关键词: 再灌注损伤, 缺氧缺血,脑, 疾病模型,动物, 桑黄素, TXNIP/NLRP3/Caspase-1信号通路, 神经元凋亡

Abstract:

Objective To investigate the influence of Morin on neuronal apoptosis in cerebral ischemia-reperfusion rats by regulating TXNIP/NLRP3/Caspase-1 signaling pathway. Methods Sixty rats were randomly grouped into the sham operation group, the model group, the Morin low-dose group (Morin-L, 10 mg/kg), the Morin high-dose group (Morin-H, 40 mg/kg), the Morin-H+pLVX-NC group (40 mg/kg Morin+pLVX-NC) and Morin-H+pLVX-TXNIPgroup (pLVX-TXNIP, 40 mg/kg Morin+pLVX-TXNIP). The rat middle cerebral artery embolism model was established by the suture method (except for the sham group), and then perfused after 1 h of administration. After 72 hours of perfusion, neurological deficits were scored. The whole brain was removed for brain edema determination. Hematoxylin-Eosin (HE) staining was performed to observe the pathological damage in the penumbra area of brain tissue. TTC was performed to detect the infarct size of brain tissue. ELISA was performed to detect serum contents of IL-1β and IL-18. Western blot assay was used to detect expression levels of TXNIP/NLRP3/Caspase-1 signaling pathway-related proteins in brain tissue. Results Compared with the sham operation group, the neurological deficit score, contents of IL-1β and IL-18, brain water content, infarct size, expression levels of TXNIP, NLRP3 and Caspase-1 proteins were increased in the model group (P<0.05). Compared with the model group, the neurological deficit score, contents of IL-1β and IL-18, brain water content, infarct size, expression levels of TXNIP, NLRP3 and Caspase-1 proteins were decreased in the Morin-L group and the Morin-H group (P<0.05). Compared with Morin-H+pLVX-NC group, the neurological deficit score, contents of IL-1β and IL-18, brain water content, infarct size, expression levels of TXNIP, NLRP3 and Caspase-1 proteins were increased in the Morin-H+pLVX-TXNIP group (P<0.05). Conclusion Morin can reduce brain injury and inhibit neuronal apoptosis in rats with cerebral ischemia-reperfusion, which may be related to the inhibition of TXNIP/NLRP3/Caspase-1 signaling pathway.

Key words: reperfusion injury, hypoxia-ischemia, brain, disease models, animal, Samlutein, TXNIP/NLRP3/Caspase-1 signaling pathway, apoptosis of neuron

中图分类号: